Investor Investigation of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) over Potential Securities Laws Violations
An investigation on behalf of investors of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) shares over potential securities laws violations by SciClone Pharmaceuticals, and certain of its directors and officers in connection certain financial statements was announced.
View full press release